The DABTAPE Imperative, and KiOR’s Fall from Equity Market Grace
by Jim Lane (BioInvest Digest) ...KiOR’s fallen into the penalty box this week — it’s stock falling from a high of nearly $5 just a week ago — now disappearing into the sub-$3 range as the company missed production